Astrocytoma is a common malignant primary brain tumor with a poor clinical prognosis in both adults and children [1–3]. The therapeutic options for the treatment of patients with astrocytoma are limited to three fundamental modalities: surgical resection, chemotherapy, and radiation therapy [4–6]. Cellular adoptive immunotherapy with specific CTLs has been recently used to treat malignant tumors [7–9].